Correlation Between Enbridge and Tissue Regenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enbridge and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enbridge and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enbridge and Tissue Regenix Group, you can compare the effects of market volatilities on Enbridge and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enbridge with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enbridge and Tissue Regenix.

Diversification Opportunities for Enbridge and Tissue Regenix

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Enbridge and Tissue is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Enbridge and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and Enbridge is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enbridge are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of Enbridge i.e., Enbridge and Tissue Regenix go up and down completely randomly.

Pair Corralation between Enbridge and Tissue Regenix

Assuming the 90 days trading horizon Enbridge is expected to generate 0.48 times more return on investment than Tissue Regenix. However, Enbridge is 2.1 times less risky than Tissue Regenix. It trades about 0.78 of its potential returns per unit of risk. Tissue Regenix Group is currently generating about -0.05 per unit of risk. If you would invest  5,870  in Enbridge on October 21, 2024 and sell it today you would earn a total of  490.00  from holding Enbridge or generate 8.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy68.42%
ValuesDaily Returns

Enbridge  vs.  Tissue Regenix Group

 Performance 
       Timeline  
Enbridge 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Enbridge are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Enbridge unveiled solid returns over the last few months and may actually be approaching a breakup point.
Tissue Regenix Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Enbridge and Tissue Regenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enbridge and Tissue Regenix

The main advantage of trading using opposite Enbridge and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enbridge position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.
The idea behind Enbridge and Tissue Regenix Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments